We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+17.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.22B
AUM Growth
-$65.3M
Cap. Flow
-$208M
Cap. Flow %
-16.99%
Top 10 Hldgs %
34.8%
Holding
287
New
134
Increased
23
Reduced
46
Closed
28

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$20.6M
2
HGV icon
Hilton Grand Vacations
HGV
+$19M
3
CVNA icon
Carvana
CVNA
+$12.5M
4
NATL icon
NCR Atleos
NATL
+$9.39M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$6.39M

Top Sells

Rank Stock Value
1
ENVA icon
Enova International
ENVA
+$28.6M
2
FLG
Flagstar Bank National Association
FLG
+$24.5M
3
VST icon
Vistra
VST
+$18.3M
4
NE icon
Noble Corp
NE
+$16.1M
5
PHIN icon
Phinia Inc
PHIN
+$8.72M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Consumer Discretionary 18.74%
3 Financials 10.52%
4 Materials 4.8%
5 Industrials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENCPW
251
DELISTED
Energem Corp Warrant
ENCPW
$1.13K ﹤0.01%
75,000
– –
FEXDW
252
DELISTED
Fintech Ecosystem Development Corp. Warrant
FEXDW
$698 ﹤0.01%
75,000
– –
LIBYW
253
DELISTED
Liberty Resources Acquisition Corp. Warrant
LIBYW
$625 ﹤0.01%
125,000
– –
VSACW
254
DELISTED
Vision Sensing Acquisition Corp. Warrants
VSACW
$451 ﹤0.01%
75,000
– –
GSMGW
255
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$416 ﹤0.01%
115,589
– –
ALNY icon
256
PUT
Alnylam Pharmaceuticals
ALNY
$28.9B
– –
-10,000
Closed -$1.77M
ATRA icon
257
Atara Biotherapeutics
ATRA
$74.3M
– –
-48,000
Closed -$1.78M
BABA icon
258
Alibaba
BABA
$304B
– –
-65,000
Closed -$5.64M
CLF icon
259
Cleveland-Cliffs
CLF
$6.98B
– –
-200,000
Closed -$3.13M
CLF icon
260
PUT
Cleveland-Cliffs
CLF
$6.98B
– –
-200,000
Closed -$3.13M
CRGO icon
261
Freightos
CRGO
$64.6M
– –
-10,800
Closed -$24.8K
CVNA icon
262
CALL
Carvana
CVNA
$75.1B
– –
-1,125,000
Closed -$9.45M
HES
263
DELISTED
Hess
HES
– –
-50,000
Closed -$7.65M
IOVA icon
264
CALL
Iovance Biotherapeutics
IOVA
$2.77B
– –
-250,000
Closed -$1.14M
MRNA icon
265
PUT
Moderna
MRNA
$21.5B
– –
-15,000
Closed -$1.55M
NUVB icon
266
Nuvation Bio
NUVB
$2.15B
– –
-1,249,473
Closed -$1.67M
TSLA icon
267
Tesla
TSLA
$1.26T
– –
-15,000
Closed -$3.56M
VAL icon
268
PUT
Valaris
VAL
$5.36B
– –
-50,000
Closed -$3.75M
VST icon
269
PUT
Vistra
VST
$47.7B
– –
-150,000
Closed -$4.98M
XPER icon
270
Xperi
XPER
$331M
– –
-122,000
Closed -$1.2M
ZYME icon
271
Zymeworks
ZYME
$1.7B
– –
-64,900
Closed -$411K
OCEAW
272
DELISTED
Ocean Biomediacal, Inc. Warrants
OCEAW
– –
-150,000
Closed -$22.7K
BHAC
273
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
– –
-500,000
Closed -$5.26M
MRT.WS
274
DELISTED
Marti Technologies, Inc. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
MRT.WS
– –
-100,000
Closed -$1.81K
OHAAW
275
DELISTED
OPY Acquisition Corp. I Warrant
OHAAW
– –
-375,000
Closed -$10.4K
8 9 10
11
12

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

683 Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, 683 Capital Management held 287 positions worth $1.22B, down 5.1% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

683 Capital Management withdrew a net $208M in Q4 2023, closing 28 positions and reducing 46 holdings. Its most notable exit was Hess, an estimated $7.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in NCR Atleos worth $9.96M.

  • 683 Capital Management's largest Q4 2023 buy was NCR Atleos: 410,000 shares worth $9.96M.
  • 683 Capital Management added most to BorgWarner in Q4 2023, an estimated $20.6M increase.
  • 683 Capital Management's biggest Q4 2023 reduction was Enova International, cutting an estimated $28.6M.
  • 683 Capital Management fully exited Hess in Q4 2023, selling an estimated $7.65M.
  • 683 Capital Management's ten largest holdings make up 35% of its $1.22B portfolio in Q4 2023.
  • 683 Capital Management opened 134 new positions and closed 28 in Q4 2023.
  • 683 Capital Management's portfolio value fell 5.1% quarter-over-quarter to $1.22B.

Based on 683 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.